Board member since 2024. 

Born 1971.  

Mats has solid experience from the financial markets, mainly focused on the life science sector as an analyst and as a corporate finance advisor, as well as a professional investor with Nalka Life Science and MedCap AB, among others, over the past two decades. He is CEO and a Board member of Vixco Capital AB and a Board member of Arcoma AB, Arcoma Incentive AB, Herantis Pharma Oyj, FluoGuide A/S, Bioporto A/S and Xbrane Biopharma AB.

MatsThorénhas previously been a Board member of C-RAD AB and also of Nalka Life Science AB.  

Holdings in C-RAD: 0